课题基金 / 基金详情

Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases

Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases
Clinical Trans Valid:心脏、肺、血液和睡眠疾病护理点技术推进中心
批准号:
10222764
负责人:
David D. McManus
金额:
$17.26万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-22 至 2023-07-31

项目摘要

项目成果

David D. McManus的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT – CLINICAL TRANSLATION AND VALIDATION CORE American healthcare is rapidly evolving to a state where efficiency and quality in health care are co-dominant drivers. Point-of-care technologies (POCT) are an important tool for providers and patients to receive immediate feedback on critical health issues. In acute care settings, caregivers need real-time POCT to guide treatment in rapidly changing circumstances; and in the outpatient setting providers are seeking ways to engage patients with preventative measures and implement precision medicine. The goal of CAPCaT is to develop and optimize novel POCT to improve the diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. The Clinical Translation and Validation (CTV) core will be responsible for validating the prototypes and establishing the feasibility of adoption of these devices in settings appropriate to the specific technology being tested. Therefore, we will maintain a broad array of services necessary to facilitate clinical research, and support the specific needs of individual projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Clinical Core
Admin Core: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases
Detecting bleeding events using EHRs for prediction in Afib
海外基金